As of 2025-07-13, the Intrinsic Value of Nov Inc (NOV) is 17.48 USD. This NOV valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 13.68 USD, the upside of Nov Inc is 27.80%.
The range of the Intrinsic Value is 13.52 - 24.78 USD
Based on its market price of 13.68 USD and our intrinsic valuation, Nov Inc (NOV) is undervalued by 27.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 13.52 - 24.78 | 17.48 | 27.8% |
| DCF (Growth 10y) | 15.87 - 27.07 | 19.86 | 45.1% |
| DCF (EBITDA 5y) | 13.62 - 16.91 | 15.26 | 11.5% |
| DCF (EBITDA 10y) | 15.59 - 19.70 | 17.56 | 28.4% |
| Fair Value | 39.19 - 39.19 | 39.19 | 186.47% |
| P/E | 14.51 - 24.58 | 19.01 | 38.9% |
| EV/EBITDA | 13.31 - 18.25 | 15.93 | 16.4% |
| EPV | 12.18 - 15.75 | 13.96 | 2.1% |
| DDM - Stable | 10.11 - 22.68 | 16.40 | 19.9% |
| DDM - Multi | 12.13 - 20.96 | 15.35 | 12.2% |
| Market Cap (mil) | 5,140.12 |
| Beta | 0.86 |
| Outstanding shares (mil) | 375.74 |
| Enterprise Value (mil) | 5,992.12 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.54% |
| Cost of Debt | 4.30% |
| WACC | 8.51% |